Potential role of adoptively transferred allogeneic WT1-specific CD4+ and CD8+ T lymphocytes for the sustained remission of refractory AML.
Kim
Y-J
YJ
Cho
S-G
SG
Lee
S
S
Kim
M-S
MS
Kim
E-K
EK
Cho
B-S
BS
Sohn
H-J
HJ
Choi
H B
HB
Eom
K-S
KS
Min
C-K
CK
Kim
H-J
HJ
Kim
Y-G
YG
Kim
D-W
DW
Lee
J-W
JW
Min
W-S
WS
Kim
C-C
CC
Kim
T-G
TG
D019264:Adoptive Transfer; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000637:transplantation; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000637:transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D016879:Salvage Therapy; D033581:Stem Cell Transplantation; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000637:transplantation; D013997:Time Factors; D014184:Transplantation, Homologous; D025721:WT1 Proteins / Q000276:immunology*
D025721:WT1 Proteins